Overexpression of WRKY70 led to the marked up-regulation of numerous target genes of WRKY70 including GSTF7 in A
GLP-1 therapies should not replace antihypertensive medications
While research is ongoing, a landmark 2022 study including more than 2,500 adults with obesity or overweight and one weight-related medical condition found that participants lost an average of 20.9% of their body weight over the course of 72 weeks, or about 16.5 months
Eating smaller portions and staying well hydrated can also help your body respond more comfortably during the early stages of treatment
Novo Nordisk) were FDA approved in 2014 and 2021, respectively, to treat obesity
Natural options such as high-protein diets, exercise routines, and personalized lifestyle adjustments remain essential tools for managing weight gain